RecruitingPhase 3NCT06136650A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)Sponsor: Merck Sharp & Dohme LLCAurora, CO · Highlands Ranch, CO · Lakewood, CO · +60 more sites
RecruitingNot applicableNCT06995898The Vanguard Study: Testing a New Way to Screen for CancerSponsor: National Cancer Institute (NCI)Cheyenne Wells, CO · Denver, CO · Fort Collins, CO · +42 more sites
RecruitingPhase not listedNCT05334069Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionSponsor: Alliance for Clinical Trials in OncologyAurora, CO · +744 more sites
RecruitingPhase 3NCT06592924Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA ResponseSponsor: Canadian Cancer Trials GroupAurora, CO · Colorado Springs, CO · +371 more sites